# STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE

> **NCT07341022** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Hospital Israelita Albert Einstein** · enrollment: 12 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Plerixafor Dose Escalation

## Key facts

- **NCT ID:** NCT07341022
- **Lead sponsor:** Hospital Israelita Albert Einstein
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-12
- **Final completion:** 2028-06
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07341022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07341022, "STEM CELL MOBILIZATION WITH HIGH-DOSE PLERIXAFOR IN PATIENTS WITH SICKLE CELL DISEASE". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07341022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*